Human arterial and venous tissues generate prostacyclin (prostaglandin x), a potent inhibitor of platelet aggregation.
about
Potential role of aspirin in the prevention of aneurysmal subarachnoid hemorrhage.Structural Basis for Iloprost as a Dual Peroxisome Proliferator-activated Receptor / AgonistVascular biology of eicosanoids and atherogenesisLipid Mediators of Allergic Disease: Pathways, Treatments, and Emerging Therapeutic TargetsEighth Gaddum Memorial Lecture. University of London Institute of Education, December 1980. Biological importance of prostacyclinA regimen for low-dose aspirin?Prostacyclin concentrations in haemolytic uraemic syndrome after acute shigellosis in childrenVascular COX-2 modulates blood pressure and thrombosis in mice.A case of hemolytic uremic syndrome improved with nitric oxide.In vitro prostacyclin production in the hemolytic-uremic syndrome.Inhibitor of prostacyclin production in sporadic haemolytic uraemic syndrome.The effect of aspirin on recurrent fetal loss in experimental antiphospholipid syndrome.Regulation of peripheral blood flow in complex regional pain syndrome: clinical implication for symptomatic relief and pain management.Reduced prostacyclin activity in systemic lupus erythematosus.Endothelium modulates vasoconstrictor response to prostaglandin I2 in rat mesenteric resistance arteries: interaction between EP1 and TP receptors.Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities.Resolvin E1 regulates adenosine diphosphate activation of human platelets.The tissue factor requirement in blood coagulation.Targeting stem cell niches and trafficking for cardiovascular therapyInhibition of vascular epoprostenol (prostacyclin, PGI2) production in vitro by plasma from healthy subjects and patients with severe renal impairmentEffects of dazoxiben and low-dose aspirin on platelet behaviour in man.Adventures in vascular biology: a tale of two mediators.Responses of human and baboon arteries to prostaglandin endoperoxides and biologically generated and synthetic prostacyclin: their relevance to cerebral arterial spasm in manThe interaction of varying doses of dipyridamole and acetyl salicylic acid on the inhibition of platelet functions and their effect on bleeding time.The pressor actions of noradrenaline and angiotension II in chronic autonomic failure treated with indomethacin.Defective alterations in the collagen network to prostacyclin in COPD lung fibroblasts.Interferon enhances prostacyclin production by cultured vascular endothelial cellsThe effects of propranolol and digoxin on the acute vascular responses to frusemide in normal man.Plasmatic regulation of vascular prostacyclin in pregnancyVascular Nitric Oxide: Formation and Function.Prostacyclin: an inflammatory paradox.Synthesis of prostaglandin I2 (prostacyclin) by cultured human and bovine endothelial cells.Ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery in clinical research.Prostacyclin (PGI2) inhibits the formation of platelet thrombi in arterioles and venules of the hamster cheek pouch.Models for investigating the aetiology of cerebral arterial spasm: comparative responses of the human basilar artery with rat colon, anococcygeus, stomach fundus, and aorta and guinea-pig ileum and colonProstanoid therapies in the management of pulmonary arterial hypertension.Prostacyclin (PGI2) inhibits the formation of platelet thrombi in arterioles and venules of the hamster cheek pouch. 1977.Prostaglandin I2 (prostacyclin).Novel insights into the vasoprotective role of heme oxygenase-1Age-related decline in prostacyclin synthesis by human aortic endothelial cells. Qualitative and quantitative analysis.
P2860
Q26998381-2D06B74F-9AF3-40DF-AF8C-999486893F2BQ27670895-9CF2CF58-8D16-4412-868C-5B35EE8215B3Q28259045-4DD303F6-06B6-4120-8DF7-B0A94D7E1479Q28276574-B04FBDA9-6AD9-4D04-BEF6-839F0E78EF53Q28277612-5F19A3E6-1E2C-43DA-BE8F-075372D04CE5Q28367365-5122F964-19C7-4148-8558-8B18DBBA7262Q30495028-11B9C332-28C6-4946-9B69-3E9E346CFF8EQ30562262-B7BAF8F8-5B36-47E3-9E05-F9C296BBF6F8Q33331348-2E40FBD6-A4E1-4D5A-A899-DB56C917D7AFQ33456213-0D2A2F14-7CC5-4A7C-8125-8349F02354A0Q33477382-712AB84B-441C-41FF-9D55-A784D16C1EA4Q33493954-036D2D0E-B076-4345-A986-2EF08E7709B0Q33506195-1769F117-ED6E-4C23-95E3-BEF4F67A4437Q33552720-4CC44C1E-8F58-4806-B7E7-C30C0AEAFB72Q33569560-3555F40B-0C0D-4A14-8D55-1B945F581299Q34245387-FCC448D3-54A6-4559-928A-76F5E237C0ACQ34315513-FCA8D54A-C2F6-4DCF-B218-B79E57CCB0B2Q34360277-080B2B5A-E60E-4EB8-A50B-DAAF7BDD7BDCQ34475689-EE3E395C-AD8E-49FB-BCF1-D7BC07CB688DQ34511925-8F169F52-543C-4BAF-87D0-4BEE8A685F88Q34512047-EF0BB078-490D-4DD6-8350-04B7F29597DBQ34515584-A2F2DF5B-C9AB-4B1B-9906-C4ECE740232FQ34516813-37A6916F-B42D-44BB-8575-394787A563D3Q34518162-5CC28398-4097-4648-9EE5-63430A417C7AQ34519066-77CEF865-C10C-493E-9927-898416BE2183Q34585087-D16BA0D6-B4C3-42EE-A216-05399AF6426CQ34600898-720178B7-8C63-4C61-B0DB-591E92F2171AQ34622569-593A6E77-0A10-4517-ADBA-F1AB8537191EQ34777523-57BEAE75-D636-43D4-86D0-7CFAB7983047Q34973956-678583CB-E32D-44DC-AEFB-96063283BA90Q35025863-B1552A5F-FE10-4324-B78A-BE021559405FQ35051655-3C23A7DB-6B64-41C8-83A3-2FC24888D012Q35158491-ABEEE36A-0F46-4F3C-BC78-6B12637F3D6CQ35177461-3108574F-E5A5-441E-9519-C81AFE32641FQ35177818-F3AB43B0-3839-4D62-8958-84FCAE617C98Q35284318-20F81F47-3E7B-4DAC-9243-1CC862C554EEQ35573696-BDFE8A10-215E-46C3-9ACC-933F120DF9EFQ35645021-BA3F7F69-5932-4F77-83C8-FF992D8987F7Q35810610-E9964CCE-978B-4C72-9C95-C6877078FECAQ35830481-7E838A65-7B9C-41AC-B0A0-F3DB3E2414F3
P2860
Human arterial and venous tissues generate prostacyclin (prostaglandin x), a potent inhibitor of platelet aggregation.
description
1977 nî lūn-bûn
@nan
1977年の論文
@ja
1977年論文
@yue
1977年論文
@zh-hant
1977年論文
@zh-hk
1977年論文
@zh-mo
1977年論文
@zh-tw
1977年论文
@wuu
1977年论文
@zh
1977年论文
@zh-cn
name
Human arterial and venous tiss ...... bitor of platelet aggregation.
@en
Human arterial and venous tiss ...... bitor of platelet aggregation.
@nl
type
label
Human arterial and venous tiss ...... bitor of platelet aggregation.
@en
Human arterial and venous tiss ...... bitor of platelet aggregation.
@nl
prefLabel
Human arterial and venous tiss ...... bitor of platelet aggregation.
@en
Human arterial and venous tiss ...... bitor of platelet aggregation.
@nl
P2093
P1433
P1476
Human arterial and venous tiss ...... bitor of platelet aggregation.
@en
P2093
P356
10.1016/S0140-6736(77)91655-5
P407
P577
1977-01-01T00:00:00Z